OncoMatch/Clinical Trials/NCT06535893
Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer
Is NCT06535893 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies multiple treatments including TN and TN-1 for breast cancer.
Treatment: TN · TN-1 — Randomized phase II trial targeting early-stage breast cancer (stage II-III) applicable to preoperative chemotherapy (NAC), comparing standard treatment with multiple experimental treatments.
Check if I qualifyExtracted eligibility criteria
Cancer type
Breast Carcinoma
Disease stage
Required: Stage II, III
Performance status
ECOG 0–1(Restricted strenuous activity)
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify